SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CHANTAL Pharmaceutical

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: J R KARY who wrote (1160)3/27/1998 11:59:00 PM
From: Norrin Radd  Read Replies (1) of 1169
 
Jim, I don't know any more than you about CHTL. You should only speculate in it if you can afford to lose your total investment as I mentioned in the first paragraph of the header in the other CHTL thread.

My optimism lies in the persistence of CB and my belief that Ethocyn is a good, possibly great, skin care product that sells pretty well when advertised. David Hasselhoff, star of TV's "Baywatch" show can endorse any product he wants, so I think he must actually like the Ethocyn product line.

I don't know if they can survive and build their cash flow enough to do national advertising. The fact that the product sells well on the Home Shopping Network is a confirmation to me that people like it. I think now CHTL needs to make a deal (w/Stanson and/or HSN) to get direct revenues from future sales on HSN.

I think traders can also make money in this stock. Witness the jump from 0.03 to 0.14-0.15 over past few weeks. CHTL is a big gamble, but if it survives, the returns on investment from current levels could be huge.

I recently added significantly to my position when stock could be had for 0.040 and 0.038. My average cost for the position is much higher though. I'd like to double its size if we see some positive signs.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext